
Expert panelists review insomnia diagnosis and clinical manifestations, non-pharmacological management, pharmacological treatment options, and new agents on the horizon.

Expert panelists review insomnia diagnosis and clinical manifestations, non-pharmacological management, pharmacological treatment options, and new agents on the horizon.


A panel of experts discusses the clinical management of diabetic macular edema and the available and upcoming treatment options.

Expert panelists provide insight on the relationship between the gut microbiome and c difficile, leading to the development of novel therapeutic approaches for infection.

Anthony M. Turkiewicz, MD; Leonard H. Calabrese, DO; Sheetal Desai, MD; and Ana-Maria Orbai, MD, MHS, share insight on currently available biologic therapies, diagnostic strategies, and real-world case scenarios of psoriatic arthritis.

In this Peer Exchange, a panel of specialists examine the current and developing treatment options for age-related macular degeneration, with a focus on faricimab.

Key insight from a panel of retinal disease specialists on the role of VEGF inhibitors in managing retinal diseases, including non-proliferative diabetic retinopathy.

Expert panelists review novel agents and best practices that have improved the treatment landscape of atopic dermatitis.

An expert multidisciplinary panel reacts to the availability of newer therapies and various strategies that may minimize adverse effects, including weight gain, from HIV treatment.

An overview of treatment advances for atopic dermatitis and the role of the nurse practitioner and physician assistant in educating patients on treatment options and helping them gain access to more novel approaches.

Experts provide an overview on the management of inflammatory bowel disease using biologics and discussing their safety and efficacy data presented at the DDW Virtual 2021.

Expert panelists provide a lively discussion on currently available pharmacologic and non-pharmacologic treatment approaches in the management of hypoglycemic episodes in patients with diabetes.

A panel discussion focused on advances in the management of treatment-resistant depression and the fundamentals of certified treatment centers for the dispensing and administration of esketamine.

Experts discuss challenges in sickle cell disease along with the available standard of care and newer FDA-approved agents used in the management of the disease.

Expert cardiologists provide a brief overview of the standard of care for lipid disorders and focus on a rapidly emerging, newer treatment option for managing dyslipidemia.

Joe Avelino, RN, BSN, MHSA, CPHQ; Rahn Bailey, MD, DFAPA; and Henry Nasrallah, MD discuss the benefits of long-acting injectables in the management of schizophrenia and system protocols that are in place for the use of long-acting injectables in an institutional setting.

Experts discuss challenges and recent guidance provided by national agencies pertaining to the opioid crisis, in addition to providing real world examples of how to implement effective management strategies into clinical practice.

Lawrence F. Eichenfield, MD; Jeffrey M. Bienstock, MD, FAAP; Peter A. Lio, MD; and Elizabeth A. Swanson, MD, provide insight on the management of atopic dermatitis and the importance of a multidisciplinary approach to care.











